Efficacy and safety of nafamostat mesylate versus heparin anticoagulation in adult kidney disease patients using continuous renal replacement therapy: a systematic review and meta-analysis

BackgroundAnticoagulation is essential during continuous renal replacement therapy (CRRT) for acute kidney injury to maintain circuit patency and balance bleeding risks.ObjectiveSystematically compare the anticoagulant efficacy and safety of nafamostat mesylate (NM) versus heparin in CRRT.MethodsWe...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yao Wang, Qiuhong He, Dan Wen, Rong Xu, Xiao Yu, Lingning Zhao
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2026-02-01
Serija:	Frontiers in Medicine
Teme:	anticoagulation continuous renal replacement therapy heparin meta-analysis nafamostat mesylate
Online dostop:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1713412/full
Oznake:	Označite Brez oznak, prvi označite!